Collegium Pharmaceutical (COLL) Notes Payables (2014)
Collegium Pharmaceutical (COLL) posted Notes Payables of $5.0 million for Q4 2014.
Powered by 
Analysis
Collegium Pharmaceutical (COLL) Notes Payables (2014) Analysis & Trends
Collegium Pharmaceutical has reported Notes Payables for 1 years, with the latest figure at $5.0 million in Q4 2014.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $5.0 million in Q4 2014; TTM through Dec 2014 was $5.0 million, a N/A change from a year earlier, with the FY2014 full-year figure at $5.0 million, changed N/A from the prior year.
- Notes Payables was $5.0 million for Q4 2014 at Collegium Pharmaceutical.
- The five-year high for Notes Payables was $5.0 million in Q4 2014, with the low at $5.0 million in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Collegium Pharmaceutical | 753.09 Mn | 603.77 Mn | 110.29 Mn |